In particular, MBP111–119–reactive CD8+ T cells, which are increased three fold in MS patients peripheral blood, are CD45RO+ memory T cells secreting TNF-α and IFN-γ after epitope challenging and are cytotoxic towards antigen presenting cells and oligodendrocytes, thus supporting the postulate that these CD8+ T cells could contribute to the tissue injury in MS [13], [15]. Here, CD8A is linked to myeloid sarcoma.